Bullisch
$2.04
Szenariopreis
$10.400
-0.099 (-0.95%)Zum Schluss
Garden Stage Ltd is a holding company principally engaged in the provision of financial services. The Company is principally engaged in the provision of securities dealing and brokerage services, securities underwriting and placing services, asset management services as well as others.
Garden Stage Ltd (GSIW) appears to be a good buy right now due to its recent price recovery and compliance with Nasdaq requirements. The stock has seen a 5-day change of +9.43% and a significant volume increase with a ratio of 8.86 times its average 20-day volume, indicating strong investor interest. Additionally, the current price of $10.04 is well below its 52-week high of $41.98, suggesting substantial upside potential. However, the company reported a net income loss of $6,494,776 in Q2 2026, which remains a significant risk.
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Garden Stage Regains Nasdaq Compliance

Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge

Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data

U.S. Stocks Rise in Morning Trading, Dow Jones Up Over 100 Points

Garden Stage Limited Announces 200-for-1 Share Consolidation
Garden Stage Ltd is a holding company principally engaged in the provision of financial services. The Company is principally engaged in the provision of securities dealing and brokerage services, securities underwriting and placing services, asset management services as well as others. It operates in the Financials sector.
Garden Stage Ltd (GSIW) appears to be a good buy right now due to its recent price recovery and compliance with Nasdaq requirements. The stock has seen a 5-day change of +9.43% and a significant volume increase with a ratio of 8.86 times its average 20-day volume, indicating strong investor interest. Additionally, the current price of $10.04 is well below its 52-week high of $41.98, suggesting substantial upside potential. However, the company reported a net income loss of $6,494,776 in Q2 2026, which remains a significant risk.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.